SCHEMBL17047714

SCHEMBL17047714

CC1=CC(=O)N(c2ccccc2)C1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MGLL Q99685 1/20 0.36
ABCB11 O95342 1/20 0.36
LMNA P02545 1/20 0.36
PTGS1 P23219 1/20 0.36
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CYP1A2 P05177 3/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23872070 0.85 HPGD (0.54) HPGDL3MBTL1MGLLLMNARAB9A
SCHEMBL17047757 0.78 HPGD (0.43) HPGDL3MBTL1MGLLRAB9ASMN1; SMN2
SCHEMBL21910199 0.78 ALDH1A1 (0.45) HPGDL3MBTL1MGLLLMNARAB9A
SCHEMBL24460831 0.71 CYTH2 (0.39) HPGDL3MBTL1LMNAPTGS1SMN1; SMN2
SCHEMBL17047692 0.70 RAB9A (0.42) ABCB11LMNAPTGS1RAB9ASMN1; SMN2
SCHEMBL10642402 0.69 MYC (0.37) HPGDMAPTMEN1KMT2ANPSR1
SCHEMBL21909811 0.69 PAX8 (0.33) MGLLABCB11LMNAPTGS1RAB9A
SCHEMBL365502 0.68 GSK3A (0.45) HPGDL3MBTL1MGLLLMNASMN1; SMN2
SCHEMBL17718383 0.68 LMNA (0.37) HPGDL3MBTL1ABCB11LMNAPTGS1
SCHEMBL10797528 0.67 MEN1 (0.44) MGLLABCB11LMNAPTGS1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210405529-A1 FILM FORMING MATERIAL FOR LITHOGRAPHY, COMPOSITION FOR FILM FORMATION FOR LITHOGRAPHY, UNDERLAYER FILM FOR LITHOGRAPHY, AND METHOD FOR FORMING PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-12-30 US disclosed
EP-3110808-B1 PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2018-08-29 EP disclosed
US-9751867-B2 Plant growth regulating compounds SYNGENTA PARTICIPATIONS AG (CH) 2017-09-05 US disclosed
EP-3110808-A1 PLANT GROWTH REGULATING COMPOUNDS Syngenta Participations AG (CH) 2017-01-04 EP disclosed
US-20160368900-A1 PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2016-12-22 US disclosed
WO-2015128321-A1 PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2015-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368900-A1 PLANT GROWTH REGULATING COMPOUNDS GHDC, GAK, EIF4G2 HPGD 769/4885L3MBTL1 4013/4885MGLL 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.